Current health reform and many prior initiatives have been moving the healthcare system towards patient-centeredness, so it’s time to take stock.
- What is patient-centeredness, actually?
- What programs are working and how do we know?
- Will patient-centeredness have staying power?
ECRI Institute’s 18th Annual Conference, is planned and co-organized by the U.S. Food and Drug Administration; in cooperation with the U.S. Agency for Healthcare Research and Quality, Health Affairs, Foundation for Informed Medical Decision-Making, Kaiser Permanente Institute for Health Policy, American Board of Internal Medicine, Milbank Memorial Fund, and the Leonard Davis Institute for Health Economics at the University of Pennsylvania.
Expected speakers include:
- Margaret Hamburg, MD, Commissioner, FDA
- Carolyn Clancy, MD, Director, Agency for Healthcare Research and Quality
- Jeffrey Shuren, MD, JD, Director, Center for Devices and Radiologic Health, FDA
- Janet Woodcock, MD, Director, Center for Drug Evaluation and Research (CDER), FDA
- Joe V. Selby, MD, MPH, Executive Director, Patient-Centered Outcomes Research Institute
- Karen Ignagni, President and CEO, American’s Health Insurance Plans
Other nationally recognized experts will include policy makers, practitioners and researchers.
This meeting, Nov. 29 & 30, will be at FDA’s White Oak Campus in Silver Spring, Md. (suburban Washington, D.C.).
There is no fee to attend the program, but space is limited and advance registration is required. The conference will be web streamed and the recording will be archived so press can attend live or by web streaming. Registration is required either way.